| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:85-97.)
© 2007 American Heart Association, Inc.
Cardiovascular Involvement in General Medical Conditions |
From the Department of Medicine (E.L.S., M.L.L.), Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada; and the Department of Nephrology and Hypertension (J.F.E.M.), Schwabing General Hospital, Ludwig Maximilians University, Munich, Germany.
Correspondence to Ernesto L. Schiffrin, MD, PhD, FRSC, FRCPC, Sir Mortimer B. Davis Jewish General Hospital, B-127, 3755 Côte Ste-Catherine Rd, Montreal, Quebec, Canada H3T 1E2. E-mail ernesto.schiffrin{at}mcgill.ca
Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic kidney disease promotes hypertension and dyslipidemia, which in turn can contribute to the progression of renal failure. Furthermore, diabetic nephropathy is the leading cause of renal failure in developed countries. Together, hypertension, dyslipidemia, and diabetes are major risk factors for the development of endothelial dysfunction and progression of atherosclerosis. Inflammatory mediators are often elevated and the renin-angiotensin system is frequently activated in chronic kidney disease, which likely contributes through enhanced production of reactive oxygen species to the accelerated atherosclerosis observed in chronic kidney disease. Promoters of calcification are increased and inhibitors of calcification are reduced, which favors metastatic vascular calcification, an important participant in vascular injury associated with end-stage renal disease. Accelerated atherosclerosis will then lead to increased prevalence of coronary artery disease, heart failure, stroke, and peripheral arterial disease. Consequently, subjects with chronic renal failure are exposed to increased morbidity and mortality as a result of cardiovascular events. Prevention and treatment of cardiovascular disease are major considerations in the management of individuals with chronic kidney disease.
Key Words: atherosclerosis hypertension kidney vasculature
This article has been cited by other articles:
![]() |
A. W.Y. Chung, H.H. C. Yang, M. K. Sigrist, G. Brin, E. Chum, W. A. Gourlay, and A. Levin Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease Cardiovasc Res, December 1, 2009; 84(3): 494 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Talmor-Barkan, G. Rashid, I. Weintal, J. Green, J. Bernheim, and S. Benchetrit Low extracellular Ca2+: a mediator of endothelial inflammation Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3306 - 3312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Al-Mallah, R. Hachamovitch, S. Dorbala, and M. F. Di Carli Incremental Prognostic Value of Myocardial Perfusion Imaging in Patients Referred to Stress Single-Photon Emission Computed Tomography With Renal Dysfunction Circ Cardiovasc Imaging, November 1, 2009; 2(6): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ino, C. Kojima, M. Osaka, K. Nitta, and M. Yoshida Dynamic Observation of Mechanically-Injured Mouse Femoral Artery Reveals an Antiinflammatory Effect of Renin Inhibitor Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1858 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease Diabetes Care, November 1, 2009; 32(suppl_2): S314 - S321. [Full Text] [PDF] |
||||
![]() |
M. J. Postma and D. de Zeeuw The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2975 - 2983. [Full Text] [PDF] |
||||
![]() |
H. Kastarinen, O. Ukkola, and Y. A. Kesaniemi Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2767 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W.Y. Chung, H.H. C. Yang, J. M. Kim, M. K. Sigrist, E. Chum, W. A. Gourlay, and A. Levin Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease Circulation, September 1, 2009; 120(9): 792 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Obermayr, C. Temml, G. Gutjahr, A. Kainz, R. Klauser-Braun, R. Fugger, and R. Oberbauer Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2421 - 2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koleganova, G. Piecha, E. Ritz, P. Schirmacher, A. Muller, H.-P. Meyer, and M.-L. Gross Arterial calcification in patients with chronic kidney disease Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2488 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Bahlmann and D. Fliser The plasticity of progenitor cells--why is it of interest to the nephrologists? Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2018 - 2020. [Full Text] [PDF] |
||||
![]() |
T. Tsutamoto, C. Kawahara, M. Yamaji, K. Nishiyama, M. Fujii, T. Yamamoto, and M. Horie Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure Eur J Heart Fail, July 1, 2009; 11(7): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Niizuma, Y. Iwanaga, T. Yahata, Y. Tamaki, Y. Goto, H. Nakahama, and S. Miyazaki Impact of Left Ventricular End-Diastolic Wall Stress on Plasma B-Type Natriuretic Peptide in Heart Failure with Chronic Kidney Disease and End-Stage Renal Disease Clin. Chem., July 1, 2009; 55(7): 1347 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Lopes, F. da Silva Paulitsch, A. Pereira, C. L. Garzillo, J. F. Ferreira, N. Stolf, and W. Hueb Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1443 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aikawa, M. Aikawa, P. Libby, J.-L. Figueiredo, G. Rusanescu, Y. Iwamoto, D. Fukuda, R. H. Kohler, G.-P. Shi, F. A. Jaffer, et al. Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease Circulation, April 7, 2009; 119(13): 1785 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jara, C. Chacon, M. E. Burgos, A. Droguett, A. Valdivieso, M. Ortiz, P. Troncoso, and S. Mezzano Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1121 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gimelli, G. Rossi, P. Landi, P. Marzullo, G. Iervasi, A. L'Abbate, and D. Rovai Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease J. Nucl. Med., April 1, 2009; 50(4): 546 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.E. Angermann Comorbidities in heart failure: a key issue Eur J Heart Fail Suppl, April 1, 2009; 8(suppl_1): i5 - i10. [Full Text] [PDF] |
||||
![]() |
N. Thilly, S. Boini, M. Kessler, S. Briancon, and L. Frimat Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale) Nephrol. Dial. Transplant., March 1, 2009; 24(3): 934 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ilyas, N. Dhaun, D. Markie, P. Stansell, J. Goddard, D.E. Newby, and D.J. Webb Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease QJM, March 1, 2009; 102(3): 183 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele Medications Impair Kidney Function in Stroke Population--Reply Arch Neurol, March 1, 2009; 66(3): 416 - 416. [Full Text] [PDF] |
||||
![]() |
T. Keller, C. M. Messow, E. Lubos, V. Nicaud, P. S. Wild, H. J. Rupprecht, C. Bickel, S. Tzikas, D. Peetz, K. J. Lackner, et al. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study Eur. Heart J., February 1, 2009; 30(3): 314 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and A. C. Montezano Vascular smooth muscle cells sense calcium: a new paradigm in vascular calcification Cardiovasc Res, February 1, 2009; 81(2): 237 - 239. [Full Text] [PDF] |
||||
![]() |
M. Kobayashi, N. Hirawa, K. Yatsu, Y. Kobayashi, Y. Yamamoto, S. Saka, D. Andoh, Y. Toya, G. Yasuda, and S. Umemura Relationship between silent brain infarction and chronic kidney disease Nephrol. Dial. Transplant., January 1, 2009; 24(1): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, and K. N. Vemmos Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality Nephrol. Dial. Transplant., January 1, 2009; 24(1): 194 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.C. Bennett, S. Silverman, P.S. Gill, and G.Y.H. Lip Ethnicity and peripheral artery disease QJM, January 1, 2009; 102(1): 3 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. McCullough, V. Agrawal, E. Danielewicz, and G. S. Abela Accelerated Atherosclerotic Calcification and Monckeberg's Sclerosis: A Continuum of Advanced Vascular Pathology in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1585 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Nickolas, M. Khatri, B. Boden-Albala, K. Kiryluk, X. Luo, P. Gervasi-Franklin, M. Paik, and R. L. Sacco The Association Between Kidney Disease and Cardiovascular Risk in a Multiethnic Cohort: Findings From the Northern Manhattan Study (NOMAS) Stroke, October 1, 2008; 39(10): 2876 - 2879. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. W. J. Sijpkens, N. C. Berkhout-Byrne, and T. J. Rabelink Optimal predialysis care NDT Plus, October 1, 2008; 1(suppl_4): iv7 - iv13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Craig and J. M. Hunter Recent developments in the perioperative management of adult patients with chronic kidney disease Br. J. Anaesth., September 1, 2008; 101(3): 296 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Bennett Reporting eGFR Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1561 - 1562. [Full Text] [PDF] |
||||
![]() |
J. R. Brown, R. P. Cochran, T. A. MacKenzie, A. P. Furnary, K. S. Kunzelman, C. S. Ross, C. W. Langner, D. C. Charlesworth, B. J. Leavitt, L. J. Dacey, et al. Long-Term Survival After Cardiac Surgery is Predicted by Estimated Glomerular Filtration Rate Ann. Thorac. Surg., July 1, 2008; 86(1): 4 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ovbiagele Impairment in Glomerular Filtration Rate or Glomerular Filtration Barrier and Occurrence of Stroke Arch Neurol, July 1, 2008; 65(7): 934 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Siragy and C. Xue Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats Exp Physiol, July 1, 2008; 93(7): 817 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Rodionov and S. R. Lentz The Homocysteine Paradox Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1031 - 1033. [Full Text] [PDF] |
||||
![]() |
M. I. Yilmaz, M. Saglam, A. R. Qureshi, J. J. Carrero, K. Caglar, T. Eyileten, A. Sonmez, E. Cakir, Y. Oguz, A. Vural, et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kanda, S. Wakino, K. Hayashi, and J. Plutzky Cardiovascular Disease, Chronic Kidney Disease, and Type 2 Diabetes Mellitus: Proceeding with Caution at a Dangerous Intersection J. Am. Soc. Nephrol., January 1, 2008; 19(1): 4 - 7. [Full Text] [PDF] |
||||
![]() |
M. Kruk, J. Kadziela, H. R. Reynolds, S. A. Forman, Z. Sadowski, B. A. Barton, D. B. Mark, A. P. Maggioni, J. Leor, J. G. Webb, et al. Predictors of Outcome and the Lack of Effect of Percutaneous Coronary Intervention Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction. Results From the Occluded Artery Trial (OAT). J. Am. Coll. Cardiol. Intv., January 1, 2008; 1: 511 - 520. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |